Tag: oral gonadotropin-releasing hormone

Home / oral gonadotropin-releasing hormone

Categories

The FDA has approved relugolix for the treatment of advanced prostate cancer

August 2021: The first oral gonadotropin-releasing hormone (GnRH) receptor antagonist, relugolix (ORGOVYX, Myovant Sciences, Inc.), was approved by the Food and Drug Administration on December 18, 202...
oral-gonadotropin-releasing-hormone

Scan the code